Development of Innovative Polymer-Based Matricial Nanostructures for Ritonavir Oral Administration

Table 1

Composition of nanoparticles (EUD = Eudragit® RS100, PCLT = polycaprolactone triol, and RIT = ritonavir).

	NPR-300	NPR-900
Aqueous phase
Polysorbate 80 (mg)	76	76
Water (mL)	54	54
Organic phase
EUD (mg)	100	100
PCLT 300 (mg)	330	—
PCLT 900 (mg)	—	330
Acetone (mL)	27	27
RIT (mg)	10	10